Jillian Marie Hagel serves as Executive at Enveric Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jillian Marie Hagel has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 25, 2023 involved receiving (via award) 12,000 shares valued at $0.
Jillian Marie Hagel currently holds 35,802 shares of Enveric Biosciences, Inc. (ENVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jillian Marie Hagel has been a net neutral trader of ENVB stock. They have purchased $0 and sold $0 worth of shares.
Jillian Marie Hagel's most recent insider trade was on Jan 25, 2023, when they sold 12,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 13, 2021 | ENVB | $0 | Award | 1,021 | $N/A | Discretionary |
| Sep 16, 2021 | ENVB | $0 | Award | 531,602 | $N/A | Discretionary |
| Sep 16, 2021 | ENVB | $0 | Award | 82,398 | $N/A | Discretionary |